Catalyst Wire Dossier Catalyst Wire Dossier

Ibuprofen 200 mg and Diphenhydramine Citrate 38 mg

Ibuprofen; Diphenhydramine citrate · PLD Acquisitions LLC DBA Avma Pharma Solutions
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Ibuprofen 200 mg and Diphenhydramine Citrate 38 mg, covering 2024-04-11 to 2024-04-11. Get the full timeline:

Most recent: FDA Approved: IBUPROFEN 200 MG AND DIPHENHYDRAMINE CITRATE 38 MG — Original Application (PLD Acquisitions LLC DBA Avma Pharma Solutions)

See pricing